AGI.do

Products

What will AGI do for Asocainol?

This classification denotes an antiarrhythmic agent with the molecular formula C27H31NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) J40338OKKT, chemically known as (+-)-6,7,8,9-tetrahydro-2,12-dimethoxy-7-methyl-6-phenethyl-5h-dibenz(d,f)azonin-1-ol but more generally known as asocainol, which bears US NIH Compound Identifier 71161. Asocainol most often comes in base and hydrochloride forms. European Medicines Agency schedules Asocainol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05583MIG. The term ASOCAINOL is an International Non-Proprietary Name. ASOCAINOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule asocainol under HS 29339990 and SITC 51577. As of Q4 2014, ASOCAINOL remains US FDA's Preferred Term for this commodity. Asocainol bears US NLM identifiers UMLS ID C0052513 and NCI Concept Code C72574. SMILES: OC1C2C(CC(N(CCC3C2CC(OC)CC3)C)CCC2CCCCC2)CCC1OC.

How AGI delivers it

Four ways AGI delivers for Asocainol

  • Headless SaaS for Agents

    Give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

    For Asocainol, give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

  • Services-as-Software

    Get the professional outcome delivered as software, priced on results, not headcount.

    For Asocainol, get the professional outcome delivered as software, priced on results, not headcount.

Go deeper

Explore Asocainol

Read the deeper take on agi.asView as markdown